Lacrisert (Bausch & Lomb Incorporated)


Welcome to the PulseAid listing for the Lacrisert drug offered from Bausch & Lomb Incorporated. This Demulcent [EPC],Demulcent Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Bausch & Lomb Incorporated
NON-PROPRIETARY NAME: hydroxypropyl cellulose
SUBSTANCE NAME: HYDROXYPROPYL CELLULOSE (TYPE H)
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Demulcent [EPC],Demulcent Activity [MoA]
ROUTE: OPHTHALMIC
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1981-06-01
END MARKETING DATE: 0000-00-00


Lacrisert HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLacrisert from Bausch & Lomb Incorporated
LABELER NAME: Bausch & Lomb Incorporated
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/1)
START MARKETING DATE: 1981-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 24208-800_b3714b67-261a-40fd-977b-48c688daace1
PRODUCT NDC: 24208-800
APPLICATION NUMBER: NDA018771

Other HYDROXYPROPYL CELLULOSE (TYPE H) Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Bausch & Lomb IncorporatedLacrisert